Bristol-Myers Squibb Company
Patents, Design & Utilities
Last updated:
List of all Bristol-Myers Squibb Company patents 772 in total
| Status | Patent |
|---|---|
Grant | Utility: Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Filling date: 6 Sep 2025 Issue date: 20 Jul 2021 |
Grant | Utility: Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Filling date: 6 Sep 2025 Issue date: 20 Jul 2021 |
Grant | Utility: Substituted bicyclic compounds Filling date: 6 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: CAMK2D antisense oligonucleotides and uses thereof Filling date: 6 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Methods for the selection of binding proteins Filling date: 6 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Oxime ether compounds Filling date: 6 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Triazolopyridine inhibitors of myeloperoxidase Filling date: 6 Sep 2025 Issue date: 13 Jul 2021 |
Application | Utility: CRYSTALLINE FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-- YL)PHENYL)AMINO)-N-(METHYL-D3) PYRIDAZINE-3-CARBOXAMIDE Filling date: 6 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT Filling date: 6 Sep 2025 Issue date: 8 Jul 2021 |
Grant | Utility: 4-azaindole compounds Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Carbazole derivatives Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Pyrimidinones as factor XIA inhibitors Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Tangential flow filtration based protein refolding methods Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Pyrimidine carboxamides as GSK-3 inhibitors Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Application | Utility: MODIFIED RELAXIN POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCER AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: IMAGING METHODS USING 18F-RADIOLABELED BIOLOGICS Filling date: 6 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: APELIN RECEPTOR AGONISTS AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 1 Jul 2021 |
Grant | Utility: Alkylphenyl compounds Filling date: 6 Sep 2025 Issue date: 29 Jun 2021 |
Grant | Utility: Substituted isoquionline derivatives as immunomudulators Filling date: 6 Sep 2025 Issue date: 29 Jun 2021 |
Application | Utility: TL1A ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: 3-SUBSTITUTED PROPIONIC ACIDS AS ALPHA V INTEGRIN INHIBITORS Filling date: 6 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: TRICYCLIC HETEROARYL-SUBSTITUTED QUINOLINE AND AZAQUINOLINE COMPOUNDS AS PAR4 INHIBITORS Filling date: 6 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS T CELL ACTIVATORS Filling date: 6 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: DIAZASPIRO ROCK INHIBITORS Filling date: 6 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: Antisense Oligonucleotides Targeting Alpha-Synuclein and Uses Thereof Filling date: 6 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: ALKENE SPIROCYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS Filling date: 6 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: IMPROVED PROTEIN RECOVERY Filling date: 6 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: TIM-3 ANTAGONISTS FOR THE TREATMENT AND DIAGNOSIS OF CANCERS Filling date: 6 Sep 2025 Issue date: 10 Jun 2021 |
Grant | Utility: Indazole derivatives as alpha v integrin antagonists Filling date: 6 Sep 2025 Issue date: 8 Jun 2021 |
Application | Utility: ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS Filling date: 6 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS Filling date: 6 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: Febrifugine Derivatives Filling date: 6 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: CYCLOHEXYL ACID TRIAZOLE AZOLES AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 3 Jun 2021 |
Grant | Utility: Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses Filling date: 6 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Antibody-drug conjugate with a tubulysin analog warhead having a stabilized acetate group in the TUV subunit Filling date: 6 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Sulfone pyridine alkyl amide-substituted heteroaryl compounds Filling date: 6 Sep 2025 Issue date: 1 Jun 2021 |
Application | Utility: IMMUNOTHERAPEUTIC DOSING REGIMENS COMPRISING POMALIDOMIDE AND AN ANTI-CS1 ANTIBODY FOR TREATING CANCER Filling date: 6 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: SERIALLY-CONNECTABLE DRUG MODULES FOR COMBINATORIAL DRUG DELIVERY DEVICE Filling date: 6 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: ASSAY TO DETERMINE IN VIVO RECEPTOR OCCUPANCY Filling date: 6 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: ANTI-CD27 ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: SPIROHEPTANYL HYDANTOINS AS ROCK INHIBITORS Filling date: 6 Sep 2025 Issue date: 27 May 2021 |
Grant | Utility: Cyclobutane- and azetidine-containing mono and spirocyclic compounds as .alpha.V integrin inhibitors Filling date: 6 Sep 2025 Issue date: 25 May 2021 |
Application | Utility: COMPOUNDS USEFUL AS INHIBITORS OF HELIOS PROTEIN Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: COMBINATORIAL DRUG DELIVERY DEVICE Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: ANTICANCER COMBINATION THERAPY WITH CD73 ANTAGONIST ANTIBODY AND PD-1/PD-L1 AXIS ANTAGONIST ANTIBODY Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: SMALL MOLECULE INHIBITORS OF GALECTIN-3 Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: OXIME ETHER COMPOUNDS Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: ALKYLPHENYL COMPOUNDS Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: PHENYLACETAMIDES AS INHIBITORS OF ROCK Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Showing 250 to 300 of 772 patents.